Today we're talking about Neuralink, Elon Musk's biotech startup that's working on connecting the human brain to computers. Just recently, the company announced its plan to commence human clinical trials, aiming to implant brain chips in paralysis patients. This development comes with its share of ethical questions, technological hurdles, and regulatory complications, but it also presents transformative possibilities for how we could interact with machines in the future.
Neuralink revealed through a company blog post that it has initiated recruitment for its first human trials, known as the PRIME Study—standing for Precise Robotically Implanted Brain-Computer Interface. With the blessings of an independent review board, Neuralink will be focusing on testing the safety and efficacy of these implants.